Trends in surgical complexity in ovarian cancer surgery in the era of increasing neoadjuvant chemotherapy: A National Cancer Database study

被引：0
|
作者：
Horner, W. [1 ]
Pleasant, V. [1 ]
Peng, K. [1 ]
Brackmann, M. [1 ]
Ebott, J. A. [1 ]
Gutfreund, R. [1 ]
Reynolds, R. K. [2 ]
Uppal, S. [1 ]
机构：
[1] Univ Michigan Hosp, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2228
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [21] Refusal of recommended chemotherapy for ovarian cancer: Risk factors and outcomes, a National Cancer Database study
    Lin, J. F.
    Cliby, B. A.
    Leiserowitz, G. S.
    Tergas, A. I.
    Bristow, R. E.
    Wallace, S.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 186 - 186
  • [22] Neoadjuvant chemotherapy in ovarian cancer
    Camci, C
    Balat, O
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2002, 23 (05) : 437 - 441
  • [23] Neoadjuvant chemotherapy and ovarian cancer
    Ray-Coquard, Isabelle
    Saba, Chadi
    Bachelot, Thomas
    Meeus, Pierre
    Mignotte, Herve
    Blondet, Remy
    Treilleux, Isabelle
    Peix, Marie
    Guastalla, Jean-Paul
    BULLETIN DU CANCER, 2006, 93 (07) : 669 - 676
  • [24] NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER: TRENDS IN UTILIZATION AND IMPLICATIONS FOR PATHOLOGIC STAGING IN THE NATIONAL CANCER DATABASE
    Patel, Sanjay G.
    Stimson, C. J.
    Zaid, Harras B.
    Barocas, Daniel A.
    Resnick, Matthew J.
    Cookson, Michael S.
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E719 - E720
  • [25] Neoadjuvant chemotherapy for ovarian cancer
    Vergote, I
    Van Gorp, T
    Amant, F
    Neven, P
    Berteloot, P
    ONCOLOGY-NEW YORK, 2005, 19 (12): : 1615 - 1622
  • [26] Interval debulking surgery is not worth the wait: A National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy
    Lyons, Y. A.
    Reyes, H. D.
    McDonald, M.
    Newtson, A. M.
    Devor, E.
    Bender, D. P.
    Goodheart, M. J.
    Bosquet, J. Gonzalez
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 210 - 211
  • [27] Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy
    Lyons, Yasmin A.
    Reyes, Henry D.
    McDonald, Megan E.
    Newtson, Andreea
    Devor, Eric
    Bender, David P.
    Goodheart, Michael J.
    Bosquet, Jesus Gonzalez
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (06) : 845 - 852
  • [28] Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?
    Aytekin, Okan
    Kerinc, Simge Kirmizigul
    Tokalioglu, Abdurrahman Alp
    Ucar, Yesim Ozkaya
    Kilic, Fatih
    Comert, Gunsu Kimyon
    Ucar, Gokhan
    Civelek, Burak
    Turan, Taner
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [29] Ovarian cancer patients selected for neoadjuvant chemotherapy vs. primary debulking surgery are not similar - A national cancer data base study
    Leiserowitz, G. S.
    Lin, J. F.
    Tergas, A. I.
    Cliby, W. A.
    Bristow, R. E.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 382 - 383
  • [30] The management of epithelial ovarian cancer: neoadjuvant chemotherapy and interval surgery
    Allen, D. G.
    SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 2 (02) : 67 - 68
12345